Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Transferrin receptor expression in the human placenta.

G Bergamaschi1, P Bergamaschi, S Carlevati

  • 1Dipartimento di Medicina Interna e Terapia Medica, Università di Pavia, Italy.

Haematologica
|May 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prolonged-release pirfenidone in patients with pulmonary fibrosis as a phenotype of post-acute sequelae of COVID-19 pneumonia. Safety and efficacy.

Respiratory medicine·2023
Same author

The mechanical and chemical stability of the interfaces in bioactive materials: The substrate-bioactive surface layer and hydroxyapatite-bioactive surface layer interfaces.

Materials science & engineering. C, Materials for biological applications·2020
Same author

Therapy-related myelodysplastic syndromes deserve specific diagnostic sub-classification and risk-stratification-an approach to classification of patients with t-MDS.

Leukemia·2020
Same author

A continuous-time Markov model approach for modeling myelodysplastic syndromes progression from cross-sectional data.

Journal of biomedical informatics·2020
Same author

Pharmacology and Therapeutics of Bronchodilators Revisited.

Pharmacological reviews·2019
Same author

Bioactive materials: In vitro investigation of different mechanisms of hydroxyapatite precipitation.

Acta biomaterialia·2019
Same journal

Emapalumab and eltrombopag rescue for prolonged immune effector cell-associated hemophagocytic syndrome after CAR T-cell therapy in multiple myeloma.

Haematologica·2026
Same journal

Incidence and predictors of recurrent venous thromboembolism after isolated distal deep vein thrombosis: a <i>post-hoc</i> analysis of the RIDTS trial.

Haematologica·2026
Same journal

Philadelphia positive T-acute lymphoblastic leukemia: a Mayo Clinic series.

Haematologica·2026
Same journal

Long-term follow-up of oral decitabine/cedazuridine plus venetoclax for older or unfit patients with newly diagnosed acute myeloid leukemia.

Haematologica·2026
Same journal

Reframing leukemia-niche interactions: the emerging role of the marrow adipocyte lineage.

Haematologica·2026
Same journal

A novel dose-dense strategy for CD19-directed CAR T-cell therapy is associated with durable responses without increased toxicity in patients with B-cell non-Hodgkin lymphoma.

Haematologica·2026
See all related articles

Placental iron uptake is regulated by transferrin receptors. Higher placental non-heme iron levels correlate with lower transferrin receptor expression, suggesting a feedback mechanism in iron transport.

Area of Science:

  • Obstetrics and Gynecology
  • Maternal-Fetal Medicine
  • Human Physiology

Background:

  • Maternal-fetal iron transfer is crucial for fetal development.
  • Transferrin receptors at the placenta mediate iron uptake from maternal plasma.
  • Understanding placental iron regulation is vital for healthy pregnancies.

Purpose of the Study:

  • To measure placental transferrin receptor content in normal pregnancies.
  • To investigate the relationship between transferrin receptor expression and placental non-heme iron.
  • To explore correlations with maternal and fetal iron status.

Main Methods:

  • Assessed placental transferrin receptor content indirectly via transferrin binding capacity.
  • Quantified non-heme iron content in placental tissue.

Related Experiment Videos

  • Analyzed relationships between transferrin receptor levels, non-heme iron, and maternal/fetal iron status.

    • Main Results:

    • Placental transferrin receptor content varied significantly (mean 96 +/- 37 µg/g).
    • Non-heme iron content averaged 78 +/- 11 µg/g.
    • A significant inverse relationship was observed between transferrin receptor content and non-heme iron (r = 0.64, p < 0.025).

    Conclusions:

    • Placental non-heme iron appears to regulate transferrin receptor expression.
    • This suggests a feedback mechanism controlling placental iron uptake.
    • Iron storage within the placenta may modulate iron delivery to the fetus.